- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Aegerion Pharmaceuticals Inc+ Add to Watchlist
AEGR:US21.6400 USD 12.5700 36.74%
As of 10:07:30 ET on 10/31/2014.
Company Profile for Aegerion Pharmaceuticals Inc (AEGR)
Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches small-molecule therapeutics for cardiovascular and metabolic disease. Aegerion's product candidates limit secretion of cholesterol and triglycerides.
Aegerion Pharmaceuticals Inc
Key Executives for Aegerion Pharmaceuticals Inc (AEGR)
|Marc D BeerChief Executive Officer||Mark J FitzpatrickChief Financial Officer|
|Craig FraserChief Operating Officer||Mark SumerayChief Medical Officer|
|Carolina AlarcoPresident:International||Martha J CarterSenior VP/Chief Regulatory|
|Anne Marie CookSenior VP/Secretary/Gen Cnsl|